Haleon plc Director/PDMR Shareholding Notification

This filing is a report by Haleon plc detailing transactions by Persons Discharging Managerial Responsibilities (PDMRs) on September 24, 2026. The report, in accordance with UK Market Abuse Regulation, discloses the acquisition of ordinary shares through dividend reinvestment by two PDMRs: Dawn Allen (Chief Financial Officer) and Brian McNamara. Dawn Allen acquired 2,317.19703 shares at a price of £3.44631 per share on the London Stock Exchange. Brian McNamara acquired 12,208.83196 ordinary shares at the same price per share. The filing also includes a brief overview of Haleon as a consumer healthcare company with a portfolio spanning various health categories and well-known brands.